Component

Human postprandial circulating apolipoprotein B-48

Species, exposure, manipulation and limitations are specified on each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Acarbose pretreatment prevented the 120-minute ApoB-48 increase after the sucrose-containing mixed meal.

    Experimental context and source evidence
    dose
    Meal with 50 g added sucrose in 200 mL; with or without 100 mg acarbose before meal
    duration
    GLP-1 through 60 minutes; ApoB-48 at 120 minutes
    evidence_access
    Primary full-text methods/results and metadata inspected.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    Healthy Japanese men; 21 total, 12 in acarbose comparison
    exposure_scope
    Sucrose-containing mixed meal, drug and peptide response
    limitations
    Mixed meal includes starch, protein and fat. Association does not prove intact sucrose sensing by human L cells or GLP-1 mediation of ApoB-48; proposed paracrine mechanism remains a hypothesis.
    nutrient_topic
    Sucrose chapter; direct sucrose observations are distinguished from shared component metabolism. · Sucrose
    organism
    Healthy Japanese men; 21 total, 12 in acarbose comparison
    plain_language
    Acarbose pretreatment prevented the 120-minute ApoB-48 increase after the sucrose-containing mixed meal.
    primary_references
    Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener. (2012). https://pubmed.ncbi.nlm.nih.gov/24843559/ DOI: 10.1111/j.2040-1124.2011.00163.x
    route
    Oral mixed meal and drug
    tissue
    Plasma active GLP-1 and ApoB-48 after mixed meal

    Sucrose: mechanism of action and metabolic impact (2026-09-20) · lines 283–293

    Original AI-assisted source-specific sucrose curation with shared canonical claims retained by identity. Primary-study citations, negative findings, exposure details and limitations preserved. Not publisher full text. · supports · Healthy Japanese men; 21 total, 12 in acarbose comparison · source_derived_draft · unverified_draft

    ## sucrose-acarbose-apob48 Acarbose pretreatment prevented the 120-minute ApoB-48 increase after the sucrose-containing mixed meal. Model/species: Healthy Japanese men; 21 total, 12 in acarbose comparison Tissue: Plasma active GLP-1 and ApoB-48 after mixed meal Exposure: Meal with 50 g added sucrose in 200 mL; with or without 100 mg acarbose before meal Route: Oral mixed meal and drug Duration: GLP-1 through 60 minutes; ApoB-48 at 120 minutes Exposure scope: Sucrose-containing mixed meal, drug and peptide response Limits: Mixed meal includes starch, protein and fat. Association does not prove intact sucrose sensing by human L cells or GLP-1 mediation of ApoB-48; proposed paracrine mechanism remains a hypothesis. Reference: Glucagon-like peptide-1 secretion by direct stimulation of L cells with luminal sugar vs non-nutritive sweetener. (2012). https://pubmed.ncbi.nlm.nih.gov/24843559/ DOI: 10.1111/j.2040-1124.2011.00163.x Access: Primary full-text methods/results and metadata inspected.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards